Operational Challenges and Forex Headwinds Hurt Zoetis Q3 Peformance, Cuts FY22 Outlook

  • Zoetis Inc ZTS has reported Q3 FY22 revenue of $2.0 billion, an increase of 1% Y/Y, missing the consensus of $2.09 billion.
  • Adjusted EPS was $1.21, down 3% Y/Y, missing the consensus of $1.25.
  • "We reported 2% operational growth in adjusted net income this quarter. This lower-than-usual growth on the bottom line was due primarily to a more favorable tax rate in the year-ago quarter," said Kristin Peck, CEO.
  • Revenue in the U.S. segment was $1.090 billion, an increase of 2%. Sales of companion animal products increased by 6%.
  • Revenue in the International segment was $889 million, a decrease of 2% on a reported basis and an increase of 8% operationally.
  • The company lowered 2022 guidance to reflect lower-than-expected sales in 2H related to continued supply constraints, veterinary workforce challenges, and recent changes to foreign exchange rates.
  • Guidance: Zoetis expects FY22 sales of $8-$8.075 billion, compared to $8.23 - $8.33 billion expected earlier and the consensus of $8.26 billion.
  • The company forecasts adjusted EPS of $4.83-$4.90, down from the previous guidance of $4.97 - $5.05 and the consensus of $5.00.
  • Price Action: ZTS shares are down 11.6% at $130.38 on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsLarge CapNewsGuidanceHealth CareMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!